Basiliximab Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.1 Immunomodulators Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Basiliximab Manufacturers of Basiliximab Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Basiliximab's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 20 mg20 (20)As recommended.IV Inf665 ug/min For 30 minutes, repeat after 4 days, as required. Paedriatic Dosage (20kg) 12 mg/sq.meter22 (22)As recommended.IV InfusionOver20-30 minutes, repeate after 4 days Neonatal Dosage (3kg) Not recommended in this age group High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Basiliximab Back to top Manufacturers of Basiliximab in Pakistan Novartis Back to top Previous Drug Generic - Next Drug Generic
Basiliximab Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.1 Immunomodulators Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Basiliximab Manufacturers of Basiliximab Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Basiliximab's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 20 mg20 (20)As recommended.IV Inf665 ug/min For 30 minutes, repeat after 4 days, as required. Paedriatic Dosage (20kg) 12 mg/sq.meter22 (22)As recommended.IV InfusionOver20-30 minutes, repeate after 4 days Neonatal Dosage (3kg) Not recommended in this age group High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Basiliximab Back to top Manufacturers of Basiliximab in Pakistan Novartis Back to top Previous Drug Generic - Next Drug Generic